Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 6.56525252 |
2 | regulation of sequestering of triglyceride (GO:0010889) | 4.73437675 |
3 | desmosome organization (GO:0002934) | 4.65194046 |
4 | regulation of cholesterol storage (GO:0010885) | 4.61551196 |
5 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.51471001 |
6 | brown fat cell differentiation (GO:0050873) | 4.42075792 |
7 | cell-substrate junction assembly (GO:0007044) | 4.33502313 |
8 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.94519158 |
9 | lymph vessel development (GO:0001945) | 3.90528282 |
10 | muscle cell migration (GO:0014812) | 3.84447853 |
11 | surfactant homeostasis (GO:0043129) | 3.83464120 |
12 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.80815221 |
13 | triglyceride catabolic process (GO:0019433) | 3.79634393 |
14 | white fat cell differentiation (GO:0050872) | 3.77080897 |
15 | positive regulation of macrophage cytokine production (GO:0060907) | 3.73884109 |
16 | endodermal cell differentiation (GO:0035987) | 3.73478422 |
17 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.73387628 |
18 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.72079554 |
19 | skin morphogenesis (GO:0043589) | 3.71397900 |
20 | ovulation from ovarian follicle (GO:0001542) | 3.54370979 |
21 | hemidesmosome assembly (GO:0031581) | 3.51945501 |
22 | negative regulation of protein localization to cell surface (GO:2000009) | 3.47805125 |
23 | lipid storage (GO:0019915) | 3.43615606 |
24 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.42547318 |
25 | apoptotic cell clearance (GO:0043277) | 3.39399706 |
26 | extracellular fibril organization (GO:0043206) | 3.37428439 |
27 | valine metabolic process (GO:0006573) | 3.36262029 |
28 | phagocytosis, recognition (GO:0006910) | 3.34583593 |
29 | mesodermal cell differentiation (GO:0048333) | 3.30842326 |
30 | acylglycerol catabolic process (GO:0046464) | 3.30215452 |
31 | neutral lipid catabolic process (GO:0046461) | 3.30215452 |
32 | cell adhesion mediated by integrin (GO:0033627) | 3.23898109 |
33 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.22650607 |
34 | collagen fibril organization (GO:0030199) | 3.20236041 |
35 | negative regulation of anoikis (GO:2000811) | 3.18881141 |
36 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.18351158 |
37 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.16748459 |
38 | barbed-end actin filament capping (GO:0051016) | 3.15154392 |
39 | fatty acid transmembrane transport (GO:1902001) | 3.13505675 |
40 | protein hydroxylation (GO:0018126) | 3.12949573 |
41 | negative regulation of lipid storage (GO:0010888) | 3.10178677 |
42 | lymphangiogenesis (GO:0001946) | 3.10172457 |
43 | regulation of endothelial cell differentiation (GO:0045601) | 3.08662562 |
44 | positive regulation of osteoblast proliferation (GO:0033690) | 3.05906093 |
45 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.05265286 |
46 | lipid particle organization (GO:0034389) | 3.04659062 |
47 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.04590009 |
48 | renal filtration (GO:0097205) | 3.04361490 |
49 | negative regulation of protein autophosphorylation (GO:0031953) | 3.03943337 |
50 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.03367465 |
51 | growth hormone receptor signaling pathway (GO:0060396) | 3.00482818 |
52 | cell migration involved in heart development (GO:0060973) | 3.00252766 |
53 | chemical homeostasis within a tissue (GO:0048875) | 2.99567634 |
54 | hypotonic response (GO:0006971) | 2.99346030 |
55 | keratinocyte proliferation (GO:0043616) | 2.99286073 |
56 | doxorubicin metabolic process (GO:0044598) | 2.94945324 |
57 | daunorubicin metabolic process (GO:0044597) | 2.94945324 |
58 | polyketide metabolic process (GO:0030638) | 2.94945324 |
59 | protein localization to cell surface (GO:0034394) | 2.94653214 |
60 | plasma membrane repair (GO:0001778) | 2.94578878 |
61 | glomerular filtration (GO:0003094) | 2.93330740 |
62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93327455 |
63 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.92469491 |
64 | regulation of vasculogenesis (GO:2001212) | 2.89917019 |
65 | type B pancreatic cell proliferation (GO:0044342) | 2.87593912 |
66 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.85769993 |
67 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.85636253 |
68 | fibril organization (GO:0097435) | 2.85547234 |
69 | positive regulation of focal adhesion assembly (GO:0051894) | 2.83037536 |
70 | positive regulation of cell junction assembly (GO:1901890) | 2.83037536 |
71 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.82439014 |
72 | lung vasculature development (GO:0060426) | 2.81494193 |
73 | positive regulation of lipid storage (GO:0010884) | 2.78134241 |
74 | positive regulation of adherens junction organization (GO:1903393) | 2.77940715 |
75 | negative regulation of monooxygenase activity (GO:0032769) | 2.77498641 |
76 | actin filament depolymerization (GO:0030042) | 2.77333538 |
77 | positive regulation of glomerulus development (GO:0090193) | 2.76264873 |
78 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.76009198 |
79 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.75973000 |
80 | peptidyl-proline hydroxylation (GO:0019511) | 2.75906105 |
81 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.75756334 |
82 | pericardium development (GO:0060039) | 2.75664808 |
83 | positive regulation of fatty acid oxidation (GO:0046321) | 2.75420436 |
84 | regulation of macrophage cytokine production (GO:0010935) | 2.75046921 |
85 | protein heterotrimerization (GO:0070208) | 2.74680061 |
86 | cell-substrate adherens junction assembly (GO:0007045) | 2.74678197 |
87 | focal adhesion assembly (GO:0048041) | 2.74678197 |
88 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.74512589 |
89 | endocardial cushion development (GO:0003197) | 2.73102932 |
90 | regulation of metalloenzyme activity (GO:0048552) | 2.73005387 |
91 | stress fiber assembly (GO:0043149) | 2.72690894 |
92 | biotin metabolic process (GO:0006768) | 2.70239937 |
93 | wound healing, spreading of epidermal cells (GO:0035313) | 2.69112813 |
94 | atrioventricular valve morphogenesis (GO:0003181) | 2.68677431 |
95 | epithelial cell-cell adhesion (GO:0090136) | 2.68226117 |
96 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.67973040 |
97 | transcytosis (GO:0045056) | 2.67888025 |
98 | negative regulation of cartilage development (GO:0061037) | 2.67623065 |
99 | positive regulation of endothelial cell migration (GO:0010595) | 2.66986699 |
100 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.66621259 |
101 | axon extension involved in axon guidance (GO:0048846) | 2.65200395 |
102 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.65200395 |
103 | regulation of anoikis (GO:2000209) | 2.63577295 |
104 | negative regulation of fatty acid transport (GO:2000192) | 2.63438651 |
105 | heart trabecula formation (GO:0060347) | 2.61909967 |
106 | regulation of the force of heart contraction (GO:0002026) | 2.60680562 |
107 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.60589436 |
108 | endothelium development (GO:0003158) | 2.60309626 |
109 | adherens junction assembly (GO:0034333) | 2.60221113 |
110 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.60021095 |
111 | substrate-dependent cell migration (GO:0006929) | 2.59763548 |
112 | extracellular matrix assembly (GO:0085029) | 2.59369893 |
113 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.58338791 |
114 | triglyceride biosynthetic process (GO:0019432) | 2.58254609 |
115 | endothelial cell morphogenesis (GO:0001886) | 2.57388424 |
116 | gap junction assembly (GO:0016264) | 2.56844168 |
117 | regulation of lipid storage (GO:0010883) | 2.56712306 |
118 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.56310406 |
119 | cellular response to growth hormone stimulus (GO:0071378) | 2.55662075 |
120 | positive regulation of receptor recycling (GO:0001921) | 2.55144693 |
121 | basement membrane organization (GO:0071711) | 2.55032957 |
122 | smooth muscle tissue development (GO:0048745) | 2.54673313 |
123 | negative regulation of heart growth (GO:0061117) | 2.54478590 |
124 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.54478590 |
125 | blood vessel remodeling (GO:0001974) | 2.54041347 |
126 | neutral lipid biosynthetic process (GO:0046460) | 2.52719623 |
127 | acylglycerol biosynthetic process (GO:0046463) | 2.52719623 |
128 | response to hyperoxia (GO:0055093) | 2.52030896 |
129 | response to increased oxygen levels (GO:0036296) | 2.52030896 |
130 | positive regulation of epithelial cell migration (GO:0010634) | 2.51561872 |
131 | cellular response to vitamin D (GO:0071305) | 2.51333664 |
132 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.50492966 |
133 | * membrane raft organization (GO:0031579) | 2.50484990 |
134 | cellular response to vitamin (GO:0071295) | 2.50363316 |
135 | protein localization to endosome (GO:0036010) | 2.50255735 |
136 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.49873364 |
137 | Golgi transport vesicle coating (GO:0048200) | 2.48723964 |
138 | COPI coating of Golgi vesicle (GO:0048205) | 2.48723964 |
139 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.48337132 |
140 | sprouting angiogenesis (GO:0002040) | 2.48263379 |
141 | blood vessel maturation (GO:0001955) | 2.47994652 |
142 | regulation of receptor binding (GO:1900120) | 2.46945924 |
143 | kidney mesenchyme development (GO:0072074) | 2.46444454 |
144 | positive regulation of vasculogenesis (GO:2001214) | 2.46420829 |
145 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.46056698 |
146 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.45641362 |
147 | regulation of plasminogen activation (GO:0010755) | 2.44656333 |
148 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44605846 |
149 | cell-matrix adhesion (GO:0007160) | 2.43867178 |
150 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43610534 |
151 | mammary gland development (GO:0030879) | 2.43319615 |
152 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.43079139 |
153 | endothelial cell chemotaxis (GO:0035767) | 2.42711520 |
154 | cellular response to lithium ion (GO:0071285) | 2.42247010 |
155 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.36180722 |
156 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.34597975 |
157 | fatty acid beta-oxidation (GO:0006635) | 2.32651585 |
158 | * membrane assembly (GO:0071709) | 2.32467333 |
159 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.32317713 |
160 | glycerolipid catabolic process (GO:0046503) | 2.31811944 |
161 | morphogenesis of an endothelium (GO:0003159) | 2.31585597 |
162 | endothelial tube morphogenesis (GO:0061154) | 2.31585597 |
163 | ovulation (GO:0030728) | 2.30411341 |
164 | positive regulation of cholesterol efflux (GO:0010875) | 2.30368896 |
165 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30130039 |
166 | artery development (GO:0060840) | 2.30011427 |
167 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.29155956 |
168 | plasma lipoprotein particle clearance (GO:0034381) | 2.29122611 |
169 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.26907610 |
170 | lung lobe morphogenesis (GO:0060463) | 2.26897941 |
171 | positive regulation of glucose import (GO:0046326) | 2.26500076 |
172 | regulation of smooth muscle cell migration (GO:0014910) | 2.25600019 |
173 | iron ion import (GO:0097286) | 2.23726550 |
174 | endocrine hormone secretion (GO:0060986) | 2.21665528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.51344807 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.67652578 |
3 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.25251122 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.11126853 |
5 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.82083292 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70592736 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.55154469 |
8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.25797850 |
9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.21470640 |
10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.14001687 |
11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.10655701 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.07894268 |
13 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.02550790 |
14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01907732 |
15 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.96492691 |
16 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.88433204 |
17 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.88433204 |
18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.82172769 |
19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.81738934 |
20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.75932826 |
21 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75443023 |
22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73422711 |
23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71065086 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70220837 |
25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.69785747 |
26 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67358690 |
27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66847229 |
28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66281025 |
29 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.65190359 |
30 | ATF3_27146783_Chip-Seq_COLON_Human | 1.65117179 |
31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63724017 |
32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63693184 |
33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.62675881 |
34 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.59003678 |
35 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58152486 |
36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.58121183 |
37 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.54960685 |
38 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.54045757 |
39 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53330231 |
40 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.51829708 |
41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50280201 |
42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.49127084 |
43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48738875 |
44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48216901 |
45 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.46268578 |
46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41649980 |
47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40689053 |
48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.39575172 |
49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.39575172 |
50 | RXR_22108803_ChIP-Seq_LS180_Human | 1.38439720 |
51 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.37835949 |
52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37661340 |
53 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36258800 |
54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34943300 |
55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34900138 |
56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34622644 |
57 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.34274748 |
58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34108279 |
59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32109512 |
60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31387318 |
61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30748681 |
62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30576380 |
63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30430678 |
64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23854096 |
65 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23799540 |
66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23799540 |
67 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.22786717 |
68 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22732978 |
69 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22113525 |
70 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20927846 |
71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20898666 |
72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20147670 |
73 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.18498077 |
74 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17669328 |
75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16898808 |
76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15566899 |
77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15369564 |
78 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.14237332 |
79 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13266533 |
80 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.13231394 |
81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12726280 |
82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12628073 |
83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11130519 |
84 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10622557 |
85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09535593 |
86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09509836 |
87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08944711 |
88 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08483035 |
89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08184466 |
90 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06323128 |
91 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06170052 |
92 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.05441080 |
93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05432833 |
94 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05320152 |
95 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.05317729 |
96 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.05317729 |
97 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05066832 |
98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04563248 |
99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03461474 |
100 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03145353 |
101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01215507 |
102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00827442 |
103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00663455 |
104 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99287366 |
105 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98680607 |
106 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97239004 |
107 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97229942 |
108 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97184617 |
109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96779818 |
110 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.96598610 |
111 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.96368124 |
112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95879180 |
113 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95557475 |
114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95260302 |
115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94932610 |
116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93227485 |
117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91964436 |
118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91741081 |
119 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91597764 |
120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90536971 |
121 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.90300415 |
122 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90165165 |
123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89623817 |
124 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.88776728 |
125 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88760654 |
126 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.88726840 |
127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88328229 |
128 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86285156 |
129 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85606416 |
130 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85595435 |
131 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85445455 |
132 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85351850 |
133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84412061 |
134 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82385092 |
135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.81962826 |
136 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.80678946 |
137 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.80050706 |
138 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.78994493 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 4.25060516 |
2 | MP0008438_abnormal_cutaneous_collagen | 3.78610564 |
3 | MP0004130_abnormal_muscle_cell | 3.42242946 |
4 | MP0003191_abnormal_cellular_cholesterol | 3.32239196 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.27236272 |
6 | MP0003724_increased_susceptibility_to | 3.19088570 |
7 | MP0001879_abnormal_lymphatic_vessel | 3.06861881 |
8 | MP0005666_abnormal_adipose_tissue | 3.00077341 |
9 | MP0009780_abnormal_chondrocyte_physiolo | 2.92530723 |
10 | MP0004185_abnormal_adipocyte_glucose | 2.88021715 |
11 | MP0005275_abnormal_skin_tensile | 2.76809510 |
12 | MP0003828_pulmonary_edema | 2.68423679 |
13 | MP0003950_abnormal_plasma_membrane | 2.58076224 |
14 | MP0000013_abnormal_adipose_tissue | 2.56022359 |
15 | MP0005167_abnormal_blood-brain_barrier | 2.49753311 |
16 | MP0010368_abnormal_lymphatic_system | 2.40857285 |
17 | MP0005503_abnormal_tendon_morphology | 2.30286505 |
18 | MP0005375_adipose_tissue_phenotype | 2.27725437 |
19 | * MP0004272_abnormal_basement_membrane | 2.24137316 |
20 | MP0001958_emphysema | 2.02578576 |
21 | MP0000749_muscle_degeneration | 1.90004824 |
22 | MP0000762_abnormal_tongue_morphology | 1.85365927 |
23 | MP0005257_abnormal_intraocular_pressure | 1.85158086 |
24 | MP0003045_fibrosis | 1.81625007 |
25 | MP0004782_abnormal_surfactant_physiolog | 1.73746586 |
26 | MP0002971_abnormal_brown_adipose | 1.73307608 |
27 | MP0000343_altered_response_to | 1.73277111 |
28 | MP0005164_abnormal_response_to | 1.71880292 |
29 | MP0000003_abnormal_adipose_tissue | 1.70850233 |
30 | MP0009115_abnormal_fat_cell | 1.69292219 |
31 | MP0002837_dystrophic_cardiac_calcinosis | 1.62377464 |
32 | MP0003566_abnormal_cell_adhesion | 1.61273331 |
33 | MP0003941_abnormal_skin_development | 1.60859261 |
34 | MP0006138_congestive_heart_failure | 1.57296988 |
35 | MP0002295_abnormal_pulmonary_circulatio | 1.51103027 |
36 | MP0002166_altered_tumor_susceptibility | 1.45515432 |
37 | MP0010234_abnormal_vibrissa_follicle | 1.44754833 |
38 | MP0003279_aneurysm | 1.42978615 |
39 | MP0003690_abnormal_glial_cell | 1.42241678 |
40 | * MP0002332_abnormal_exercise_endurance | 1.41999606 |
41 | MP0002876_abnormal_thyroid_physiology | 1.33140201 |
42 | MP0005334_abnormal_fat_pad | 1.31022692 |
43 | MP0000733_abnormal_muscle_development | 1.27986444 |
44 | MP0005388_respiratory_system_phenotype | 1.25214520 |
45 | MP0002133_abnormal_respiratory_system | 1.25214520 |
46 | MP0009053_abnormal_anal_canal | 1.24661150 |
47 | MP0001881_abnormal_mammary_gland | 1.23820745 |
48 | MP0003091_abnormal_cell_migration | 1.23817032 |
49 | MP0004883_abnormal_blood_vessel | 1.23137334 |
50 | MP0002006_tumorigenesis | 1.23028270 |
51 | MP0002060_abnormal_skin_morphology | 1.22659158 |
52 | MP0005385_cardiovascular_system_phenoty | 1.20794282 |
53 | MP0001544_abnormal_cardiovascular_syste | 1.20794282 |
54 | MP0010329_abnormal_lipoprotein_level | 1.20637211 |
55 | MP0001533_abnormal_skeleton_physiology | 1.20324815 |
56 | MP0003300_gastrointestinal_ulcer | 1.17121111 |
57 | MP0010030_abnormal_orbit_morphology | 1.16376819 |
58 | MP0002254_reproductive_system_inflammat | 1.16149054 |
59 | MP0002796_impaired_skin_barrier | 1.15374383 |
60 | MP0006054_spinal_hemorrhage | 1.15332095 |
61 | MP0004036_abnormal_muscle_relaxation | 1.14900282 |
62 | MP0002108_abnormal_muscle_morphology | 1.14213603 |
63 | MP0005595_abnormal_vascular_smooth | 1.14155365 |
64 | MP0005165_increased_susceptibility_to | 1.12686809 |
65 | MP0008775_abnormal_heart_ventricle | 1.11981778 |
66 | * MP0000759_abnormal_skeletal_muscle | 1.11804162 |
67 | MP0000467_abnormal_esophagus_morphology | 1.10987941 |
68 | MP0003075_altered_response_to | 1.10781909 |
69 | MP0000249_abnormal_blood_vessel | 1.10174712 |
70 | MP0002168_other_aberrant_phenotype | 1.09186260 |
71 | MP0002972_abnormal_cardiac_muscle | 1.08788291 |
72 | * MP0004087_abnormal_muscle_fiber | 1.08297988 |
73 | MP0001542_abnormal_bone_strength | 1.07724548 |
74 | MP0003448_altered_tumor_morphology | 1.07640992 |
75 | MP0002009_preneoplasia | 1.06285724 |
76 | MP0003186_abnormal_redox_activity | 1.06026374 |
77 | MP0005623_abnormal_meninges_morphology | 1.05282656 |
78 | MP0000579_abnormal_nail_morphology | 1.04496681 |
79 | MP0000767_abnormal_smooth_muscle | 1.04097297 |
80 | MP0001853_heart_inflammation | 1.03636518 |
81 | MP0005508_abnormal_skeleton_morphology | 1.01061075 |
82 | MP0001299_abnormal_eye_distance/ | 1.00982385 |
83 | MP0004484_altered_response_of | 0.99432621 |
84 | MP0009764_decreased_sensitivity_to | 0.98009946 |
85 | MP0005501_abnormal_skin_physiology | 0.97990668 |
86 | MP0005171_absent_coat_pigmentation | 0.97799866 |
87 | MP0005409_darkened_coat_color | 0.97342555 |
88 | MP0004147_increased_porphyrin_level | 0.97178304 |
89 | MP0005620_abnormal_muscle_contractility | 0.96744451 |
90 | MP0002998_abnormal_bone_remodeling | 0.96281328 |
91 | MP0001216_abnormal_epidermal_layer | 0.92460144 |
92 | MP0004233_abnormal_muscle_weight | 0.90073688 |
93 | MP0004215_abnormal_myocardial_fiber | 0.89670294 |
94 | MP0009785_altered_susceptibility_to | 0.88393267 |
95 | MP0009278_abnormal_bone_marrow | 0.88279272 |
96 | MP0010771_integument_phenotype | 0.88245867 |
97 | MP0002118_abnormal_lipid_homeostasis | 0.87795576 |
98 | MP0004084_abnormal_cardiac_muscle | 0.87785235 |
99 | MP0005397_hematopoietic_system_phenotyp | 0.87783068 |
100 | MP0001545_abnormal_hematopoietic_system | 0.87783068 |
101 | MP0001177_atelectasis | 0.87209785 |
102 | MP0005535_abnormal_body_temperature | 0.85977998 |
103 | MP0001243_abnormal_dermal_layer | 0.85669089 |
104 | MP0005058_abnormal_lysosome_morphology | 0.85633886 |
105 | MP0002970_abnormal_white_adipose | 0.85292348 |
106 | MP0005360_urolithiasis | 0.83969802 |
107 | MP0002234_abnormal_pharynx_morphology | 0.82389584 |
108 | MP0002269_muscular_atrophy | 0.82166790 |
109 | MP0000858_altered_metastatic_potential | 0.81262148 |
110 | MP0003868_abnormal_feces_composition | 0.80903633 |
111 | MP0002128_abnormal_blood_circulation | 0.80712790 |
112 | MP0001661_extended_life_span | 0.79393147 |
113 | MP0003303_peritoneal_inflammation | 0.79349737 |
114 | MP0000230_abnormal_systemic_arterial | 0.79271055 |
115 | MP0005197_abnormal_uvea_morphology | 0.78898479 |
116 | MP0009384_cardiac_valve_regurgitation | 0.78565137 |
117 | MP0001614_abnormal_blood_vessel | 0.77712968 |
118 | MP0001851_eye_inflammation | 0.77319005 |
119 | MP0005023_abnormal_wound_healing | 0.75822892 |
120 | MP0001756_abnormal_urination | 0.75267639 |
121 | MP0003959_abnormal_lean_body | 0.74887866 |
122 | MP0000627_abnormal_mammary_gland | 0.72792529 |
123 | MP0005330_cardiomyopathy | 0.72674614 |
124 | * MP0000750_abnormal_muscle_regeneration | 0.72454173 |
125 | MP0010630_abnormal_cardiac_muscle | 0.72190150 |
126 | MP0010352_gastrointestinal_tract_polyps | 0.71367695 |
127 | MP0002896_abnormal_bone_mineralization | 0.70682946 |
128 | MP0009250_abnormal_appendicular_skeleto | 0.70174134 |
129 | MP0002877_abnormal_melanocyte_morpholog | 0.69352681 |
130 | MP0010678_abnormal_skin_adnexa | 0.67664460 |
131 | MP0000163_abnormal_cartilage_morphology | 0.66295314 |
132 | MP0005193_abnormal_anterior_eye | 0.65716116 |
133 | MP0003453_abnormal_keratinocyte_physiol | 0.65516357 |
134 | MP0001915_intracranial_hemorrhage | 0.65477133 |
135 | MP0000751_myopathy | 0.64672708 |
136 | MP0002090_abnormal_vision | 0.64496271 |
137 | MP0009697_abnormal_copulation | 0.64382963 |
138 | MP0000747_muscle_weakness | 0.63537891 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acanthosis nigricans (HP:0000956) | 5.54477746 |
2 | Oligomenorrhea (HP:0000876) | 4.84543113 |
3 | Hematochezia (HP:0002573) | 4.20954754 |
4 | Growth hormone excess (HP:0000845) | 4.09687232 |
5 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.08961284 |
6 | Hypertriglyceridemia (HP:0002155) | 3.90771182 |
7 | Bone cyst (HP:0012062) | 3.81872737 |
8 | Increased connective tissue (HP:0009025) | 3.66223804 |
9 | Distal lower limb muscle weakness (HP:0009053) | 3.31737485 |
10 | Cerebral aneurysm (HP:0004944) | 3.18653037 |
11 | Premature rupture of membranes (HP:0001788) | 3.14584275 |
12 | Atrophic scars (HP:0001075) | 3.08530446 |
13 | Glucose intolerance (HP:0000833) | 2.99259166 |
14 | Polycythemia (HP:0001901) | 2.96591325 |
15 | Spinal rigidity (HP:0003306) | 2.92302104 |
16 | Wormian bones (HP:0002645) | 2.92285119 |
17 | Aortic dissection (HP:0002647) | 2.86559035 |
18 | Tetraparesis (HP:0002273) | 2.82767015 |
19 | Soft skin (HP:0000977) | 2.79297898 |
20 | Cardiovascular calcification (HP:0011915) | 2.77551340 |
21 | Broad metatarsal (HP:0001783) | 2.77039684 |
22 | Aortic aneurysm (HP:0004942) | 2.76340386 |
23 | Right ventricular cardiomyopathy (HP:0011663) | 2.75458936 |
24 | Short nail (HP:0001799) | 2.74194918 |
25 | Alopecia of scalp (HP:0002293) | 2.68707816 |
26 | Myocardial infarction (HP:0001658) | 2.68377127 |
27 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64007262 |
28 | Osteolytic defects of the hand bones (HP:0009699) | 2.63979501 |
29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.63979501 |
30 | Bladder diverticulum (HP:0000015) | 2.63615665 |
31 | Esophageal varix (HP:0002040) | 2.61542754 |
32 | Distal lower limb amyotrophy (HP:0008944) | 2.59821001 |
33 | Abnormality of the nasal mucosa (HP:0000433) | 2.59232570 |
34 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.59111673 |
35 | Vertebral compression fractures (HP:0002953) | 2.55552501 |
36 | Difficulty running (HP:0009046) | 2.54244159 |
37 | Interstitial pulmonary disease (HP:0006530) | 2.52604232 |
38 | Spondylolisthesis (HP:0003302) | 2.52486809 |
39 | Follicular hyperkeratosis (HP:0007502) | 2.51858525 |
40 | Ankle contracture (HP:0006466) | 2.51671824 |
41 | Hemorrhage of the eye (HP:0011885) | 2.49243770 |
42 | Mitral stenosis (HP:0001718) | 2.48875658 |
43 | Hyporeflexia of lower limbs (HP:0002600) | 2.48247401 |
44 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.46797560 |
45 | Venous abnormality (HP:0002624) | 2.45291711 |
46 | Xerostomia (HP:0000217) | 2.44673537 |
47 | Muscle fiber splitting (HP:0003555) | 2.43685863 |
48 | Vascular tortuosity (HP:0004948) | 2.43171032 |
49 | Spontaneous hematomas (HP:0007420) | 2.43063222 |
50 | Insulin resistance (HP:0000855) | 2.42860204 |
51 | Onycholysis (HP:0001806) | 2.42057013 |
52 | Thick nail (HP:0001805) | 2.40661855 |
53 | Neck muscle weakness (HP:0000467) | 2.39758957 |
54 | Fragile nails (HP:0001808) | 2.39506296 |
55 | Cervical subluxation (HP:0003308) | 2.38804023 |
56 | Hypoplasia of the iris (HP:0007676) | 2.37840246 |
57 | Pigmentary retinal degeneration (HP:0001146) | 2.37746840 |
58 | Hydroxyprolinuria (HP:0003080) | 2.36072040 |
59 | Abnormality of proline metabolism (HP:0010907) | 2.36072040 |
60 | Cerebral hemorrhage (HP:0001342) | 2.35867326 |
61 | Natal tooth (HP:0000695) | 2.34181234 |
62 | Mucosal telangiectasiae (HP:0100579) | 2.34149448 |
63 | Arterial tortuosity (HP:0005116) | 2.34127578 |
64 | Vascular calcification (HP:0004934) | 2.31749582 |
65 | Asymmetric septal hypertrophy (HP:0001670) | 2.31660862 |
66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.30916198 |
67 | Abnormal glucose tolerance (HP:0001952) | 2.30640447 |
68 | Type 1 muscle fiber predominance (HP:0003803) | 2.29054214 |
69 | Lipoatrophy (HP:0100578) | 2.27504558 |
70 | Prominent supraorbital ridges (HP:0000336) | 2.25724063 |
71 | Eczematoid dermatitis (HP:0000976) | 2.25127372 |
72 | Large hands (HP:0001176) | 2.24894391 |
73 | Elbow flexion contracture (HP:0002987) | 2.24805353 |
74 | Mitral valve prolapse (HP:0001634) | 2.24456700 |
75 | Bradycardia (HP:0001662) | 2.23809226 |
76 | Hyperpituitarism (HP:0010514) | 2.19432948 |
77 | Facial diplegia (HP:0001349) | 2.18524113 |
78 | Aplasia involving bones of the extremities (HP:0009825) | 2.18336209 |
79 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.18336209 |
80 | Aplasia of the phalanges of the hand (HP:0009802) | 2.18336209 |
81 | Plantar hyperkeratosis (HP:0007556) | 2.14458061 |
82 | Hyperthyroidism (HP:0000836) | 2.14433295 |
83 | Complement deficiency (HP:0004431) | 2.12977885 |
84 | Ventricular tachycardia (HP:0004756) | 2.12729633 |
85 | Aortic regurgitation (HP:0001659) | 2.12421131 |
86 | Milia (HP:0001056) | 2.10630072 |
87 | Subcapsular cataract (HP:0000523) | 2.10122799 |
88 | Blue sclerae (HP:0000592) | 2.10049411 |
89 | Hyperglycinuria (HP:0003108) | 2.09466630 |
90 | Generalized amyotrophy (HP:0003700) | 2.08603323 |
91 | Pterygium (HP:0001059) | 2.07764626 |
92 | Nail dystrophy (HP:0008404) | 2.06341291 |
93 | Mitral regurgitation (HP:0001653) | 2.06331775 |
94 | Hypercholesterolemia (HP:0003124) | 2.05565343 |
95 | Popliteal pterygium (HP:0009756) | 2.04943716 |
96 | Tubulointerstitial fibrosis (HP:0005576) | 2.03384373 |
97 | Camptodactyly of toe (HP:0001836) | 2.03350827 |
98 | Visceral angiomatosis (HP:0100761) | 2.02048051 |
99 | Fragile skin (HP:0001030) | 2.01414243 |
100 | Protrusio acetabuli (HP:0003179) | 2.00873479 |
101 | Congenital, generalized hypertrichosis (HP:0004540) | 2.00386576 |
102 | Myoglobinuria (HP:0002913) | 1.99488489 |
103 | Pulmonary hypertension (HP:0002092) | 1.98885516 |
104 | Venous insufficiency (HP:0005293) | 1.98433759 |
105 | Aneurysm (HP:0002617) | 1.97475105 |
106 | Wrist flexion contracture (HP:0001239) | 1.97335062 |
107 | Hypoalphalipoproteinemia (HP:0003233) | 1.97075731 |
108 | Cavernous hemangioma (HP:0001048) | 1.93975113 |
109 | Muscle stiffness (HP:0003552) | 1.93714360 |
110 | Abnormal hemoglobin (HP:0011902) | 1.92117005 |
111 | Ridged nail (HP:0001807) | 1.91916334 |
112 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91553065 |
113 | Aortic valve stenosis (HP:0001650) | 1.90910303 |
114 | Autoimmune thrombocytopenia (HP:0001973) | 1.90766222 |
115 | Rectal prolapse (HP:0002035) | 1.90478604 |
116 | Ulnar bowing (HP:0003031) | 1.90338960 |
117 | Long foot (HP:0001833) | 1.90038007 |
118 | Bundle branch block (HP:0011710) | 1.88064384 |
119 | Chondrocalcinosis (HP:0000934) | 1.87997342 |
120 | Abnormality of the calf musculature (HP:0001430) | 1.87936472 |
121 | Shallow orbits (HP:0000586) | 1.87029804 |
122 | Nephritis (HP:0000123) | 1.86790989 |
123 | Sudden death (HP:0001699) | 1.86067132 |
124 | Subacute progressive viral hepatitis (HP:0006572) | 1.85928526 |
125 | Lower limb amyotrophy (HP:0007210) | 1.85608626 |
126 | Systemic lupus erythematosus (HP:0002725) | 1.84188188 |
127 | Hemangiomatosis (HP:0007461) | 1.82574647 |
128 | Gowers sign (HP:0003391) | 1.82413968 |
129 | Dilatation of the ascending aorta (HP:0005111) | 1.80917061 |
130 | Hepatosplenomegaly (HP:0001433) | 1.80698771 |
131 | Trismus (HP:0000211) | 1.80416525 |
132 | Entropion (HP:0000621) | 1.80132649 |
133 | Short hallux (HP:0010109) | 1.79759771 |
134 | Atrial fibrillation (HP:0005110) | 1.79366030 |
135 | Abnormal delivery (HP:0001787) | 1.79092364 |
136 | Amyloidosis (HP:0011034) | 1.78519813 |
137 | Abnormality of the lumbar spine (HP:0100712) | 1.77787163 |
138 | Difficulty climbing stairs (HP:0003551) | 1.77332391 |
139 | Exercise-induced muscle cramps (HP:0003710) | 1.77288235 |
140 | Joint laxity (HP:0001388) | 1.77001847 |
141 | Nausea (HP:0002018) | 1.76911642 |
142 | Abnormality of dentin (HP:0010299) | 1.76619438 |
143 | Ectopia lentis (HP:0001083) | 1.76430472 |
144 | Abnormal atrioventricular conduction (HP:0005150) | 1.76143591 |
145 | Knee flexion contracture (HP:0006380) | 1.75754738 |
146 | Increased cerebral lipofuscin (HP:0011813) | 1.75695891 |
147 | Abnormality of Sharpey fibers (HP:0100685) | 1.75474242 |
148 | Hydroureter (HP:0000072) | 1.75440692 |
149 | Accelerated skeletal maturation (HP:0005616) | 1.75378402 |
150 | Achilles tendon contracture (HP:0001771) | 1.75288795 |
151 | Abnormality of the acetabulum (HP:0003170) | 1.74911642 |
152 | Fatigable weakness (HP:0003473) | 1.73829349 |
153 | Abnormality of the neuromuscular junction (HP:0003398) | 1.73829349 |
154 | Distal upper limb amyotrophy (HP:0007149) | 1.73493206 |
155 | Upper limb amyotrophy (HP:0009129) | 1.73493206 |
156 | Round ear (HP:0100830) | 1.73420504 |
157 | Abnormality of complement system (HP:0005339) | 1.73295504 |
158 | Thin skin (HP:0000963) | 1.73168533 |
159 | Striae distensae (HP:0001065) | 1.73092314 |
160 | Scapular winging (HP:0003691) | 1.72833433 |
161 | Abnormality of the intrinsic pathway (HP:0010989) | 1.72361570 |
162 | Coronal craniosynostosis (HP:0004440) | 1.71865819 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 4.70569349 |
2 | TGFBR2 | 2.90881192 |
3 | TRIB3 | 2.85584805 |
4 | CAMK1D | 2.83695694 |
5 | FRK | 2.68911481 |
6 | MST1R | 2.51833297 |
7 | LMTK2 | 2.47579573 |
8 | PDK2 | 2.29244637 |
9 | LIMK1 | 2.28275223 |
10 | RIPK1 | 2.26757445 |
11 | EPHB2 | 2.25514667 |
12 | FER | 2.19924897 |
13 | ERN1 | 2.11565119 |
14 | SIK1 | 2.06021581 |
15 | TTN | 2.00399330 |
16 | MST4 | 1.96355081 |
17 | MAP3K12 | 1.94812463 |
18 | MYLK | 1.87573608 |
19 | PDK4 | 1.82798675 |
20 | PDK3 | 1.82798675 |
21 | CAMK1G | 1.80130120 |
22 | KDR | 1.61807755 |
23 | MUSK | 1.51957903 |
24 | PDGFRA | 1.51241448 |
25 | ERBB4 | 1.51168168 |
26 | FGFR3 | 1.49370629 |
27 | NEK9 | 1.38262646 |
28 | CDK8 | 1.38166652 |
29 | FGFR2 | 1.37702912 |
30 | PTK2B | 1.36428703 |
31 | TRPM7 | 1.28440442 |
32 | LRRK2 | 1.25616645 |
33 | FLT3 | 1.24965720 |
34 | MET | 1.18554311 |
35 | ARAF | 1.14529114 |
36 | MAP3K3 | 1.13808469 |
37 | DDR2 | 1.10799877 |
38 | CASK | 1.10408605 |
39 | BCKDK | 1.09221955 |
40 | MAP2K1 | 1.08510512 |
41 | LATS1 | 1.08152605 |
42 | JAK1 | 1.04158619 |
43 | PIK3CA | 1.02487981 |
44 | DMPK | 1.01455124 |
45 | PTK6 | 1.00587658 |
46 | SCYL2 | 0.99785696 |
47 | NME2 | 0.99769320 |
48 | MAP3K14 | 0.99226404 |
49 | INSRR | 0.98485165 |
50 | TGFBR1 | 0.98309993 |
51 | TBK1 | 0.96784858 |
52 | STK38L | 0.94341816 |
53 | MAP3K6 | 0.90284835 |
54 | EPHB1 | 0.89949560 |
55 | MAP3K2 | 0.89576922 |
56 | DAPK2 | 0.88754379 |
57 | STK38 | 0.87231416 |
58 | CAMKK2 | 0.86064915 |
59 | PKN2 | 0.85329513 |
60 | PRKG2 | 0.85048847 |
61 | AKT3 | 0.82202558 |
62 | EPHA3 | 0.81419742 |
63 | ERBB3 | 0.81118591 |
64 | PIM2 | 0.80848921 |
65 | GRK1 | 0.80360140 |
66 | PRKCH | 0.78815794 |
67 | EIF2AK1 | 0.77763851 |
68 | PRKCE | 0.77232310 |
69 | PHKG2 | 0.76520947 |
70 | PHKG1 | 0.76520947 |
71 | CSK | 0.75898580 |
72 | PIK3CG | 0.74909064 |
73 | PRKAA2 | 0.74830697 |
74 | BMX | 0.73689355 |
75 | PDGFRB | 0.73024127 |
76 | ROCK2 | 0.71277652 |
77 | CDK6 | 0.70153267 |
78 | IGF1R | 0.69390773 |
79 | TYK2 | 0.68964292 |
80 | MELK | 0.67704439 |
81 | PDPK1 | 0.67239032 |
82 | RET | 0.64912056 |
83 | JAK2 | 0.64705834 |
84 | FGFR4 | 0.64220968 |
85 | RIPK4 | 0.63266797 |
86 | STK10 | 0.61952094 |
87 | GSK3A | 0.61662665 |
88 | PRKD2 | 0.61398030 |
89 | MAPKAPK3 | 0.59893726 |
90 | PRKD1 | 0.59178756 |
91 | MOS | 0.59044691 |
92 | INSR | 0.58831208 |
93 | EPHA2 | 0.58251650 |
94 | STK3 | 0.57949859 |
95 | PAK4 | 0.57707411 |
96 | LATS2 | 0.57519892 |
97 | PBK | 0.56909094 |
98 | BCR | 0.55453622 |
99 | ILK | 0.55223223 |
100 | PTK2 | 0.53644159 |
101 | ABL1 | 0.53317061 |
102 | ROCK1 | 0.53253886 |
103 | NEK1 | 0.50435318 |
104 | DAPK3 | 0.50344969 |
105 | STK24 | 0.49153968 |
106 | ABL2 | 0.48636998 |
107 | PAK2 | 0.48623240 |
108 | GRK7 | 0.48219947 |
109 | CAMK2G | 0.48186406 |
110 | TESK1 | 0.47411649 |
111 | GRK5 | 0.47281972 |
112 | * SRC | 0.46000563 |
113 | JAK3 | 0.45653908 |
114 | MTOR | 0.42359322 |
115 | FGFR1 | 0.41954313 |
116 | CDK9 | 0.41714531 |
117 | NTRK1 | 0.41629503 |
118 | IRAK3 | 0.41333976 |
119 | ADRBK1 | 0.39474501 |
120 | MAP2K3 | 0.39145805 |
121 | CDC42BPA | 0.38898986 |
122 | PAK1 | 0.38554347 |
123 | PDK1 | 0.38371103 |
124 | FGR | 0.37817541 |
125 | EIF2AK3 | 0.36940270 |
126 | CAMK2D | 0.36772838 |
127 | MAPKAPK5 | 0.36441849 |
128 | SIK3 | 0.27290505 |
129 | AKT2 | 0.26939107 |
130 | ICK | 0.26294509 |
131 | MAPKAPK2 | 0.23336911 |
132 | CAMK2B | 0.23330006 |
133 | CCNB1 | 0.21045441 |
134 | BRSK2 | 0.20989286 |
135 | MAP3K8 | 0.19377756 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.19198210 |
2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.07478034 |
3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.82158213 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.21802969 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20658784 |
6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.10547113 |
7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89277835 |
8 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79144795 |
9 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.78355590 |
10 | * Focal adhesion_Homo sapiens_hsa04510 | 1.68824257 |
11 | Malaria_Homo sapiens_hsa05144 | 1.66856113 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66277782 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58520407 |
14 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.47813022 |
15 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44781828 |
16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42359309 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38733307 |
18 | Amoebiasis_Homo sapiens_hsa05146 | 1.36246197 |
19 | Adherens junction_Homo sapiens_hsa04520 | 1.33872606 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.29013130 |
21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28861412 |
22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.27196076 |
23 | Phagosome_Homo sapiens_hsa04145 | 1.26023522 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20319992 |
25 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.19437492 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17293248 |
27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.17098401 |
28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12407815 |
29 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.12068732 |
30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11111098 |
31 | Lysosome_Homo sapiens_hsa04142 | 1.10038266 |
32 | Renin secretion_Homo sapiens_hsa04924 | 1.09667329 |
33 | Insulin resistance_Homo sapiens_hsa04931 | 1.09557422 |
34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09080132 |
35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08779964 |
36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08309063 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05888273 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.04608043 |
39 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01830010 |
40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01055862 |
41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98208575 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95529243 |
43 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95131767 |
44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94477818 |
45 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.94380138 |
46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91579088 |
47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90625004 |
48 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89588206 |
49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.88531961 |
50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.84874792 |
51 | Melanoma_Homo sapiens_hsa05218 | 0.84630288 |
52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84247141 |
53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84243193 |
54 | Shigellosis_Homo sapiens_hsa05131 | 0.83109899 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82880551 |
56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82335157 |
57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80648311 |
58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80312043 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.80112977 |
60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80078480 |
61 | Prion diseases_Homo sapiens_hsa05020 | 0.79728293 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.79696293 |
63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78307478 |
64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.78191815 |
65 | Legionellosis_Homo sapiens_hsa05134 | 0.77846088 |
66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77330436 |
67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76639046 |
68 | Tight junction_Homo sapiens_hsa04530 | 0.76376549 |
69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75520097 |
70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74936849 |
71 | Tuberculosis_Homo sapiens_hsa05152 | 0.74478299 |
72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74469391 |
73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74159678 |
74 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.73734366 |
75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.72954399 |
76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72514620 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.71179648 |
78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70932065 |
79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69451114 |
80 | Axon guidance_Homo sapiens_hsa04360 | 0.69342754 |
81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69168679 |
82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69005494 |
83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67529302 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67424028 |
85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66081561 |
86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65875984 |
87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64714361 |
88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64141605 |
89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64086987 |
90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63781284 |
91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63516828 |
92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63194023 |
93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62671663 |
94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61791057 |
95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61614429 |
96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61506866 |
97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61203642 |
98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60776387 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60634979 |
100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59922191 |
101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59764418 |
102 | Mineral absorption_Homo sapiens_hsa04978 | 0.59480152 |
103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59432617 |
104 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58411191 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58151792 |
106 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57126265 |
107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57058989 |
108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56001956 |
109 | Hepatitis C_Homo sapiens_hsa05160 | 0.55358812 |
110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54738392 |
111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54291056 |
112 | Salivary secretion_Homo sapiens_hsa04970 | 0.52519800 |
113 | Peroxisome_Homo sapiens_hsa04146 | 0.52287430 |
114 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50873127 |
115 | Gap junction_Homo sapiens_hsa04540 | 0.50259575 |
116 | Prostate cancer_Homo sapiens_hsa05215 | 0.49997024 |
117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48895334 |
118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48802557 |
119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48338659 |
120 | Glioma_Homo sapiens_hsa05214 | 0.48335931 |
121 | Bladder cancer_Homo sapiens_hsa05219 | 0.48090073 |
122 | Bile secretion_Homo sapiens_hsa04976 | 0.47929197 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47857192 |
124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46798320 |
125 | * Endocytosis_Homo sapiens_hsa04144 | 0.46701084 |
126 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46570530 |
127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45919870 |
128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45042387 |
129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44877536 |
130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44402387 |
131 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42956341 |
132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.42866691 |
133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42752340 |
134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42701234 |
135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42212791 |
136 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41648883 |
137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41129794 |
138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40872584 |
139 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40285102 |
140 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38241826 |
141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37431894 |
142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36538476 |
143 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36411241 |
144 | Proteasome_Homo sapiens_hsa03050 | 0.33293774 |
145 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.33062192 |